SCHEMBL19968095

SCHEMBL19968095

C=Cc1ccccc1-c1cccc2c1sc1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.48
ALOX5 P09917 1/20 0.48
GPR3 P46089 1/20 0.42
PRKDC P78527 6/20 0.40
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
BRD4 O60885 1/20 0.38
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
KCNH2 Q12809 1/20 0.38
BRDT Q58F21 1/20 0.38
SLC9A1 P19634 2/20 0.37
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.34
PAX8 Q06710 1/20 0.34
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057151 0.86 GPR3 (0.48) PARP14ALOX5GPR3PRKDCSLC9A1
SCHEMBL16553319 0.84 ALOX5 (0.61) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL19961736 0.83 PARP14 (0.51) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL431845 0.82 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL10018846 0.82 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL12996528 0.82 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL429382 0.82 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL25159583 0.78 ALOX5 (0.56) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL19961740 0.77 PARP14 (0.46) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL10029291 0.77 ALOX5 (0.54) PARP14ALOX5GPR3PRKDCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME OR10J3, CRY1, NR2E3 PARP14 2535/4885ALOX5 1190/4885GPR3 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.